tiprankstipranks
InfuSystem’s Exclusive Deal for Novel Cancer Care Device
Company Announcements

InfuSystem’s Exclusive Deal for Novel Cancer Care Device

Pick the best stocks and maximize your portfolio:

InfuSystem Holdings, Inc. ( (INFU) ) has shared an announcement.

InfuSystem Holdings, Inc. and its joint venture partner Sanara MedTech Inc. have secured an exclusive distribution agreement in the United States with ChemoMouthpiece, LLC for a novel oral cryotherapy device aimed at alleviating oral mucositis, a common side effect of chemotherapy. This partnership leverages InfuSystem’s extensive oncology network and Sanara’s strategic expertise, indicating a promising advancement for cancer patient care. The Chemo Mouthpiece® has received FDA clearance and comes with the backing of clinical validation, offering a new reimbursable treatment option for the estimated 500,000 to 1,000,000 U.S. patients affected annually by this painful condition.

See more data about INFU stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskInfuSystem Achieves Five Years of Record Revenue Growth
TipRanks Auto-Generated NewsdeskInfuSystem to Present at Sidoti Investor Conference
TheFlyInfuSystem management to meet virtually with B. Riley
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App